About this trial
This prospective, randomized, active-controlled, double-blind, parallel-group study compares the postoperative analgesic efficacy and safety of ultrasound-guided bilateral Erector Spinae Plane Block (ESPB) versus bilateral Serratus Posterior Superior Intercostal Plane Block (SPSIPB) in adult patients (45-85 years, ASA I-III) undergoing elective coronary artery bypass graft surgery. The primary outcome is postoperative pain intensity assessed by Numeric Rating Scale (NRS) at 2, 4, 8, 16, 24, and 48 hours after surgery. Secondary outcomes include intraoperative fentanyl/remifentanil consumption, postoperative morphine consumption, patient-controlled analgesia (PCA) demand/delivery parameters (if PCA is used), need for rescue analgesics, extubation and mobilization times, peak inspiratory flow measured by incentive spirometry at predefined time points, ICU and hospital length of stay, recovery quality (QoR-15 at 0, 24, and 48 hours), mortality, and block-related adverse events.
Eligibility criteria
Qualifiers
Age 45-85 years
Scheduled for elective coronary artery bypass graft (CABG) surgery
American Society of Anesthesiologists (ASA) I-II-III
Patients who provide written informed consent and agree to participate in the study
Disqualifiers
Emergency cases
ASA IV-V
Known allergy to local anesthetics
Coagulopathy (platelet count <100,000/mm³, INR >1.5, aPTT >1.5× normal)
Trial design
Treatments tested in this trial
- Ultrasound-guided Erector Spinae Plane Block (ESPB)
- Ultrasound-guided Serratus Posterior Superior Intercostal Plane Block (SPSIPB)